Methods and composition for modulating type i muscle formation using pgc-1.alpha.-
CA 2491547 A1 · Owner: Spiegelman, Bruce M. · Inventors: Spiegelman, Bruce M.; Lin, Jiandie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides novel methods and compositions for modulating type I muscle formation through modulation of PGC-1.alpha. activity or expression. Also provided are methods for identifying compounds that modulate type I muscle formation through modulation of PGC-1.alpha. activity or expression. Further provided are methods for treating disorders associated with type I and/or type II muscle formation, as well as transgenic animals expressing PGC- 1.alpha. in muscle.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 13, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 13, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 13, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.